Status:

COMPLETED

HIV Acquisition and Life Course of Born-abroad Men Who Have Sex With Men Living in Ile-de-France: the GANYMEDE Study

Lead Sponsor:

ANRS, Emerging Infectious Diseases

Collaborating Sponsors:

Institut National de la Santé Et de la Recherche Médicale, France

Conditions:

Men Who Have Sex With Men

People Living With HIV

Eligibility:

MALE

18-99 years

Brief Summary

In France, men who have sex with men (MSM) born abroad are the most affected population by HIV, in terms of HIV incidence and prevalence of undiagnosed infections. Close to 50% of born-abroad HIV-infe...

Detailed Description

A better understanding of vulnerability factors related to post-migration HIV acquisition should allow to improve HIV prevention and screening strategies among born-abroad MSM living in France. This, ...

Eligibility Criteria

Inclusion

  • Cis-gender men who report having sex with men;
  • Over 18 years of age;
  • Type 1 HIV infected;
  • Born in a country other than France and arrived in France at the age of 15 at the earliest;
  • Followed in Ile-de-France for their HIV infection and having consulted at least once in the participating center during the last 12 months;
  • Non-opposition to the collection of their health data, after being well informed of the study and the patient rights in accordance with RGPD and LIL (French regulation)

Exclusion

  • Somatic or psychiatric pathology making it impossible to participate in an investigation;
  • Communication disorder making it impossible to read (or oral responses in the event of assisted questionnaire completion).

Key Trial Info

Start Date :

April 14 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 30 2022

Estimated Enrollment :

1048 Patients enrolled

Trial Details

Trial ID

NCT04684758

Start Date

April 14 2021

End Date

June 30 2022

Last Update

July 22 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hôpital Pitié-Salpêtrière, AP-HP, Institut Pierre Louis d'Épidémiologie et de Santé Publique (iPLESP), INSERM 1136

Paris, France, 75013